+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Vaccine Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • 100 Pages
  • October 2019
  • Region: Global
  • Infinium Global Research
  • ID: 4857371
The report on the global allergy vaccine market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global allergy vaccine market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on allergy vaccine market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on allergy vaccine market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global allergy vaccine market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global allergy vaccine market over the period of 2017 to 2025. Further, the Growth Matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings:

1. Drivers
  • Growing prevalence of the allergic disease
  • New research activities for the development of allergy vaccines by private and government industries

2. Restraints
  • High costs associated with the vaccines and the presence of limited manufactures

3. Opportunities
  • Growing awareness about the allergy disease and their treatment

Research Methodology

A. Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated with the publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B. Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global allergy vaccine market is segmented on the basis of allergy type, and vaccine type.

The Global Allergy Vaccine Market by Allergy Type
  • Allergic Asthma
  • Peanut Hypersensitivity
  • Seasonal Allergic Rhinitis
  • Grass Pollen Hypersensitivity
  • Tree Pollen Hypersensitivity
  • Cat Dander Allergy
  • Other Allergy Type

The Global Allergy Vaccine Market by Vaccine Type
  • Cat Allergy Vaccine
  • Peanut Allergy Vaccine
  • House Dust Mite Allergy Vaccine
  • Injectable MPL Allergy Vaccine
  • Ragweed Allergy Immunotherapy Vaccine
  • Other Vaccine Type

Company Profiles

The companies covered in the report include
  • Circassia
  • Cytos Biotechnology AG
  • DBV Technologies SA
  • Allertein Therapeutics
  • Stallergenes Greer plc
  • Merck & Co., Inc.
  • Allergy Therapeutics
  • Novartis International AG

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the allergy vaccine market.
2. Complete coverage of all the segments in the allergy vaccine market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global allergy vaccine market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Allergy Vaccine Market Highlights
2.2. Allergy Vaccine Market Projection
2.3. Allergy Vaccine Market Regional Highlights
3. Global Allergy Vaccine Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Allergy Type
3.4.2. Growth Matrix Analysis by Vaccine Type
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Allergy Vaccine Market
4. Allergy Vaccine Market Macro Indicator Analysis
5. Global Allergy Vaccine Market by Allergy Type
5.1. Allergic Asthma
5.2. Peanut Hypersensitivity
5.3. Seasonal Allergic Rhinitis
5.4. Grass Pollen Hypersensitivity
5.5. Tree Pollen Hypersensitivity
5.6. Cat Dander Allergy
5.7. Other Allergy Type
6. Global Allergy Vaccine Market by Vaccine Type
6.1. Cat Allergy Vaccine
6.2. Peanut Allergy Vaccine
6.3. House Dust Mite Allergy Vaccine
6.4. Injectable MPL Allergy Vaccine
6.5. Ragweed Allergy Immunotherapy Vaccine
6.6. Other Vaccine Type
7. Global Allergy Vaccine Market by Region 2019-2025
7.1. North America
7.1.1. North America Allergy Vaccine Market by Allergy Type
7.1.2. North America Allergy Vaccine Market by Vaccine Type
7.1.3. North America Allergy Vaccine Market by Country
7.2. Europe
7.2.1. Europe Allergy Vaccine Market by Allergy Type
7.2.2. Europe Allergy Vaccine Market by Vaccine Type
7.2.3. Europe Allergy Vaccine Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Allergy Vaccine Market by Allergy Type
7.3.2. Asia-Pacific Allergy Vaccine Market by Vaccine Type
7.3.3. Asia-Pacific Allergy Vaccine Market by Country
7.4. RoW
7.4.1. RoW Allergy Vaccine Market by Allergy Type
7.4.2. RoW Allergy Vaccine Market by Vaccine Type
7.4.3. RoW Allergy Vaccine Market by Sub-region
8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Allergy Vaccine Market
8.2. Companies Profiled
8.2.1. Circassia
8.2.2. Cytos Biotechnology AG
8.2.3. DBV Technologies SA
8.2.4. Allertein Therapeutics
8.2.5. Stallergenes Greer plc
8.2.6. Merck & Co., Inc.
8.2.7. Allergy Therapeutics
8.2.8. Novartis International AG
9. Appendix
9.1. Primary Research Findings and Questionnaire

Companies Mentioned

  • Circassia
  • Cytos Biotechnology AG
  • DBV Technologies SA
  • Allertein Therapeutics
  • Stallergenes Greer plc
  • Merck & Co., Inc.
  • Allergy Therapeutics
  • Novartis Intertiol AG